CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Oct 07, 2024. (Total: 6342 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-12 (of 12 Records)

Query Trace: Sheu TG[original query]
Bioluminescence-based neuraminidase inhibition assay for monitoring influenza drug susceptibility in clinical specimens Marjuki H , Mishin VP , Sleeman K , Okomo-Adhiambo M , Sheu TG , Guo L , Xu X , Gubareva LV . Antimicrob Agents Chemother 2013 57 (11) 5209-15
Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors Okomo-Adhiambo M , Sheu TG , Gubareva LV . Influenza Other Respir Viruses 2013 7 Suppl 1 44-9
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Nguyen HT , Trujillo AA , Sheu TG , Levine M , Mishin VP , Shaw M , Ades EW , Klimov AI , Fry AM , Gubareva LV . Antiviral Res 2012 93 (3) 381-6
Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11. Sleeman K , Sheu TG , Moore Z , Kilpatrick S , Garg S , Fry AM , Gubareva LV . Emerg Infect Dis 2011 17 (11) 2043-2046
Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing. Levine M , Sheu TG , Gubareva LV , Mishin VP . J Clin Microbiol 2011 49 (4) 1307-12
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro Gubareva LV , Trujillo AA , Okomo-Adhiambo M , Mishin VP , Deyde VM , Sleeman K , Nguyen HT , Sheu TG , Garten RJ , Shaw MW , Fry AM , Klimov AI . Antivir Ther 2010 15 (8) 1151-9
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective Okomo-Adhiambo M , Sleeman K , Ballenger K , Nguyen HT , Mishin VP , Sheu TG , Smagala J , Li Y , Klimov AI , Gubareva LV . Viruses 2010 2 (10) 2269-2289
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays Nguyen HT , Sheu TG , Mishin VP , Klimov AI , Gubareva LV . Antimicrob Agents Chemother 2010 54 (9) 3671-7
Detection E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir-resistance Okomo-Adhiambo M , Demmler-Harrison GJ , Deyde VM , Sheu TG , Xu X , Klimov AI , Gubareva LV . Antimicrob Agents Chemother 2010 54 (5) 1834-41
Detection of molecular markers of drug resistance in the 2009 pandemic influenza A (H1N1) viruses using pyrosequencing Deyde VM , Sheu TG , Trujillo AA , Okomo-Adhiambo M , Garten R , Klimov AI , Gubareva LV . Antimicrob Agents Chemother 2009 54 (3) 1102-10
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses Okomo-Adhiambo M , Nguyen HT , Sleeman K , Sheu TG , Deyde VM , Garten RJ , Xu X , Shaw MW , Klimov AI , Gubareva LV . Antiviral Res 2009 85 (2) 381-8
Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing Sheu TG , Deyde VM , Garten RJ , Klimov AI , Gubareva LV . Antiviral Res 2009 85 (2) 354-60